Navigation Links
PAREXEL Appoints Josephine Hoppe to Chief Information Officer
Date:1/15/2009

BOSTON, Jan. 15 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services organization, announced today it has appointed Josephine Hoppe as Corporate Vice President and Chief Information Officer (CIO). Ms. Hoppe is responsible for managing the Company's information technology (IT) initiatives and integrating technology solutions with business processes on a global basis.

Prior to joining PAREXEL, Ms. Hoppe was the CIO of Pegasystems, a business process management company, where she was responsible for designing and building a comprehensive portfolio of enterprise solutions. Previously, she served as Executive Vice President and CIO of CMGI and as CIO of Addison Wesley Longman.

"PAREXEL's unique position as both the leading eClinical solutions provider, through our subsidiary Perceptive Informatics, and as one of the world's largest users of these technologies is an important differentiator in the value we are able to deliver to clients," said Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International. "In this regard, we look forward to Jo's innovation and leadership in helping PAREXEL to achieve the strategic information management objectives of the Company and its clients. She has a proven track record of achievements in the successful development and deployment of IT systems for critical business operations."

Ms. Hoppe commented, "I'm proud to join PAREXEL, which is clearly a leader in combining clinical and technology capabilities. I look forward to working with the worldwide IT leadership and staff at PAREXEL to bring even greater efficiency and flexibility to technology-driven solutions that will significantly benefit our clients and employees."

With more than 20 years of experience in IT, software produ
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...within government channels, WEST PORT, Conn., and...c. (ABH) and Regenesis Biomedical, Inc. announced ...magraft(R) within the United,States (US) governmen...Regenesis will provide its specialized sales force...eran,s Administration (VA), Department of Defense,...
...ical,Services, Inc. (NYSE: WST ) today announced ...er 2008 cash dividend of $0.14 per share. The,divi...s of record on July,23, 2008., About West Pharmac...ces, Inc. is a global manufacturer of,components a... stoppers and,seals for vials, and closures and di...
...l/Mixed tropic HIV patients with ...May 7 Pathway Diagnostics announces,nationwide av...ular,SensiTrop(TM) II assay, combining the sensiti...) technology with the specificity of molecular,seq...atus of HIV infected,patients. Pathway performs th...
Other Biology Technology:Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 2Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 3Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay 2
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2Scientists think 'killer petunias' should join the ranks of carnivorous plants 2How nutrition affects healthy aging 2Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 12429 1Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 12429 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 1Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 3Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 1Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 2
...ion, Matches with Watch-list Databases and Reports...ch 9 Neurotechnology, a provider of high-precisio...ounced the availability of VeriLook Surveillance S...identification using live video streams from high-...riLook 3.2 SDK and other facial recognition system...
...ch 12 (OTC Bulletin Board: CICI) Communication In... a leading supplier of electronic signature soluti...al industry* and the recognized leader** in biomet...ancial results for the fourth quarter and the year...the three months ended December 31, 2008 were $843...
...tion growth in southern Nevada has placed increasi...80% of the state,s residents lived in southern Nev...eople. The dual concerns of this population boom a... conditions has created an urgent demand for offic... meet resident and visitor demand., Las Vegas oper...
Other Biology News:VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 2VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 6Keeping golf courses green when fresh water is limited 2Keeping golf courses green when fresh water is limited 3
Anti-Histone H2B, acetyl (Lys20) Antibody, Unconjugated from Cell Signaling Technology
Rhodamine-B-isothiocyanate from Research Organics, Inc.
Rabbit Anti-Human MMP-7, aminoterminal end active enzyme, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-CD42d Monoclonal Antibody, Unconjugated, Clone CLB-SW16 (formerly 708) from Abcam
Biology Products: